| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |